Dyne Therapeutics, Inc. DYN Payments To Acquire Other Productive Assets
Payments To Acquire Other Productive Assets at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireOtherProductiveAssets.
The official record: Dyne Therapeutics, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s payments to acquire other productive assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s payments to acquire other productive assets?
- Dyne Therapeutics, Inc. (DYN) reported payments to acquire other productive assets of $4.7M in Q4 2025.
- What does payments to acquire other productive assets mean?
- This represents cash outflows for the acquisition of long-term assets, such as intellectual property, licenses, or specialized equipment, that are essential for research and development operations. For a biotechnology company, these investments are critical indicators of the firm's commitment to expanding its pipeline and technological capabilities. High levels of spending in this category reflect active investment in future growth and product development.